Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2010 Sep;15(17-18):773-80. doi: 10.1016/j.drudis.2010.06.009. Epub 2010 Jun 25.

Post-translational modifications of protein biopharmaceuticals.

Author information

1
Department of Chemical and Environmental Sciences and the Materials and Surface Science Institute, University of Limerick, Limerick City, Ireland. gary.walsh@ul.ie

Abstract

The majority of therapeutic proteins display one or more post-translational modifications (PTMs). These modifications normally influence the biochemical and therapeutic properties of such proteins. Choosing an expression system capable of generating an appropriate product PTM profile remains one of the most crucial decisions a drug developer must make. This review considers the PTMs most often associated with therapeutic proteins and focuses upon more recent advances in engineering PTMs with the aim of improving the application-relevant functional characteristics of these drugs.

PMID:
20599624
DOI:
10.1016/j.drudis.2010.06.009
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center